Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019

SELL
$6.15 - $10.51 $98,627 - $168,548
-16,037 Closed
0 $0
Q3 2018

Nov 05, 2018

BUY
$10.32 - $13.06 $22,951 - $29,045
2,224 Added 16.1%
16,037 $171,000
Q1 2018

May 03, 2018

SELL
$7.86 - $11.39 $3,049 - $4,419
-388 Reduced 2.73%
13,813 $118,000
Q4 2017

Feb 07, 2018

SELL
$8.77 - $12.28 $17,057 - $23,884
-1,945 Reduced 12.05%
14,201 $140,000
Q3 2017

Nov 06, 2017

BUY
$12.17 - $16.3 $196,496 - $263,179
16,146
16,146 $198,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track C World Wide Group Holding A Portfolio

Follow C World Wide Group Holding A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

News

Stay updated on C World Wide Group Holding A with notifications on news.